Rowhani-Farid, Anisa http://orcid.org/0000-0003-3637-2423
Grewal, Mikas
Solar, Steven
Eghrari, Allen O.
Zhang, Audrey D. http://orcid.org/0000-0001-9753-4276
Gross, Cary P.
Krumholz, Harlan M. http://orcid.org/0000-0003-2046-127X
Ross, Joseph S. http://orcid.org/0000-0002-9218-3320
Funding for this research was provided by:
Laura and John Arnold Foundation (No grant number, No grant number, No grant number)
Article History
Received: 30 September 2021
Accepted: 1 August 2023
First Online: 8 August 2023
Competing interests
: When this work was conducted, the salary of A.R.F. was supported by the RIAT Support Center at the University of Maryland. The RIAT Support Center was supported by the Laura and John Arnold Foundation. A.D.Z. currently receives research support from the National Institutes of Aging through the Duke Creating ADRD Researchers for the Next Generation—Stimulating Access to Research in Residency (CARiNG-StARR) programme (R38AG065762). C.P.G. has received research funding, though Yale, from the NCCN Foundation (Astra-Zeneca) and Genentech, as well as funding from Johnson and Johnson to help devise and implement new approaches to sharing clinical trial data. H.M.K. received expenses and/or personal fees from UnitedHealth, IBM Watson Health, Element Science, Aetna, Facebook, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, Martin/Baughman Law Firm, F-Prime, and the National Center for Cardiovascular Diseases in Beijing. He is an owner of Refactor Health and HugoHealth, and had grants and/or contracts from the Centers for Medicare & Medicaid Services, Medtronic, the U.S. Food and Drug Administration, Johnson & Johnson, the Foundation for a Smoke-Free World, the State of Connecticut Department of Public Health, and the Shenzhen Center for Health Information. J.S.R. currently receives research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing, from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology (NEST), from the Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938), from the Agency for Healthcare Research and Quality (R01HS022882), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R01HS025164, R01HL144644), and from Arnold Ventures; in addition, J.S.R. was an expert witness at the request of Relator’s attorneys, the Greene Law Firm, in a qui tam suit alleging violations of the False Claims Act and Anti-Kickback Statute against Biogen Inc. that was settled September 2022. M.G., S.S. and A.O.E. have no competing interests to declare.